The Rutherford Cancer Centre Thames Valley will be equipped to treat 500 patients a year.
Mike Moran, chief executive officer of Proton Partners International, which is creating a network of Rutherford Cancer Centres, said: “It’s wonderful to see another of our centres move closer to providing proton beam therapy treatment here in the UK. The Rutherford Cancer Centre Thames Valley is particularly exciting. Its close proximity to London and Heathrow allows for it to become a hub for patients in the South of England or those travelling to the UK for treatment.”
“While we know that proton therapy is not a panacea for all cancers, we have already seen the hugely positive results it can bring to patients at our centre in South Wales, and I look forward to us being able to offer that treatment across the UK.”
Olivier Legrain, Chief Executive Officer of IBA, said: “We are delighted to be working with Proton Partners International to bring high energy proton beam therapy to the UK. We are extremely proud of the Proteus®ONE solution, which is the industry’s only truly compact Image Guided Intensity Modulated Proton Therapy (IG-IMPT) solution. Having completed the installation of the Proteus®ONE solution in less than 12 months at the Rutherford Cancer Centre South Wales, we are confident that we will be able to do so again in Reading, giving residents of Thames Valley and beyond access to the latest cancer technology in due course.”
Attendees at Wednesday’s event included the Mayor of Wokingham Borough, Councillor John Kaiser, as well as Sir John Madejski, the Vice Chairman of Reading Football Club. They were joined by Professor Richard Ellis, the Director of Health Partnerships at the University of Reading, and Gordon Storey, the Deputy Lord Lieutenant of Berkshire.